BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30519093)

  • 21. Impact of the number of resected lymph nodes on postoperative survival of patients with node-negative oesophageal squamous cell carcinoma.
    Liu Q; Tan Z; Lin P; Long H; Zhang L; Rong T; Meng Y; Ma G
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):631-6. PubMed ID: 23477926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.
    Hao CL; Li Y; Yang HX; Luo RZ; Zhang Y; Zhang MF; Cheng YF; Wang X
    Int J Clin Exp Pathol; 2014; 7(7):4213-21. PubMed ID: 25120801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.
    Cheong O; Oh ST; Kim BS; Yook JH; Kim JH; Im JT; Park GC
    World J Surg; 2008 Feb; 32(2):262-6. PubMed ID: 18064519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
    Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
    Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma.
    Lin XJ; Cai LM; Qian ZJ; Wang CY; Sun N; Sun XH; Huang H; Guo WJ; Lin HY; Yao RX
    Onco Targets Ther; 2017; 10():5129-5136. PubMed ID: 29123411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
    Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
    Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
    Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Luo RZ; He LR; He JH; Huang ZL; Zeng MS; Wen ZS
    BMC Surg; 2013 May; 13():15. PubMed ID: 23711283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy.
    Aiko S; Yoshizumi Y; Ishizuka T; Sakano T; Kumano I; Sugiura Y; Maehara T
    Dis Esophagus; 2007; 20(2):94-101. PubMed ID: 17439591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of lymph node size in patients with squamous esophageal cancer.
    Dhar DK; Tachibana M; Kinukawa N; Riruke M; Kohno H; Little AG; Nagasue N
    Ann Surg Oncol; 2002 Dec; 9(10):1010-6. PubMed ID: 12464595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
    Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas.
    Toh Y; Ohga T; Endo K; Adachi E; Kusumoto H; Haraguchi M; Okamura T; Nicolson GL
    Int J Cancer; 2004 Jun; 110(3):362-7. PubMed ID: 15095300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients.
    Kadota T; Hatogai K; Yano T; Fujita T; Kojima T; Daiko H; Fujii S
    Cancer Sci; 2018 Jun; 109(6):2046-2055. PubMed ID: 29601131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of number of lymph node metastasis on survival in patients with pathological T3 esophageal carcinoma.
    Gulben K; Irkin F; Yazı M; BerberoGlu U
    Neoplasma; 2017; 64(1):131-135. PubMed ID: 27881014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer.
    Morimoto J; Tanaka H; Ohira M; Kubo N; Muguruma K; Sakurai K; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Dis Esophagus; 2014 Jan; 27(1):63-71. PubMed ID: 23480452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
    Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
    Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulation of decorin and FHL1 are associated with esophageal squamous cell carcinoma progression and poor prognosis.
    Ji C; Liu H; Xiang M; Liu J; Yue F; Wang W; Chu X
    Int J Clin Exp Med; 2015; 8(11):20965-70. PubMed ID: 26885026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast.
    Seo J; Min SK; Park HR; Kim DH; Kwon MJ; Kim LS; Ju YS
    J Breast Cancer; 2014 Dec; 17(4):323-31. PubMed ID: 25548579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.